1. Home
  2. LQDA vs BKD Comparison

LQDA vs BKD Comparison

Compare LQDA & BKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$37.68

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Brookdale Senior Living Inc.

BKD

Brookdale Senior Living Inc.

HOLD

Current Price

$12.25

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
BKD
Founded
2004
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
2018
2005

Fundamental Metrics

Financial Performance
Metric
LQDA
BKD
Price
$37.68
$12.25
Analyst Decision
Strong Buy
Buy
Analyst Count
10
5
Target Price
$38.60
$11.50
AVG Volume (30 Days)
1.9M
3.5M
Earning Date
11-03-2025
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,216,000.00
$3,083,131,000.00
Revenue This Year
$1,005.03
$8.40
Revenue Next Year
$204.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
343.41
4.35
52 Week Low
$11.26
$4.45
52 Week High
$41.57
$12.31

Technical Indicators

Market Signals
Indicator
LQDA
BKD
Relative Strength Index (RSI) 60.22 79.11
Support Level $29.41 $10.83
Resistance Level $41.57 $11.64
Average True Range (ATR) 3.03 0.36
MACD 0.43 0.07
Stochastic Oscillator 68.38 96.53

Price Performance

Historical Comparison
LQDA
BKD

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About BKD Brookdale Senior Living Inc.

Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

Share on Social Networks: